Xeljanz (Tofacitinib) Side Effects By Cristina Mutchler - Verywell Health
Xeljanz (tofacitinib citrate) is a daily oral medication that is approved to treat moderate to severe cases of rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis in adults. Xeljanz is part of a group of medications known as JAK (Janus kinase) inhibitors, which decrease inflammation by helping block an overactive immune response. Xeljanz is available in a 10 milligram (mg) twice daily dose, and a 5 mg twice daily dose, depending on your condition. It can be used alone or in combination with certain other medications, and is typically prescribed for patients who haven't had success with other classes of drugs. While Xeljanz can be an effective treatment for some people, there are both mild and serious side effects associated with the drug that you should discuss with your doctor before using. Grace Cary / Moment / Getty Images Common Side Effects Research suggests that RA patients using Xeljanz can experience a significant reducti